Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rvl Pharmaceuticals Plc (RVLP)

Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,142
  • Shares Outstanding, K 111,406
  • Annual Sales, $ 49,720 K
  • Annual Income, $ -51,690 K
  • 60-Month Beta 1.20
  • Price/Sales 0.09
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RVLP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.59
  • Most Recent Earnings $-0.13 on 08/14/23
  • Latest Earnings Date 05/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0270 +4.44%
on 10/20/23
0.1933 -85.41%
on 10/10/23
-0.0888 (-75.90%)
since 09/20/23
3-Month
0.0270 +4.44%
on 10/20/23
0.5000 -94.36%
on 08/09/23
-0.3948 (-93.33%)
since 07/20/23
52-Week
0.0270 +4.44%
on 10/20/23
1.9100 -98.52%
on 10/31/22
-1.6918 (-98.36%)
since 10/20/22

Most Recent Stories

More News
RVL Pharmaceuticals (NASDAQ: RVLP) Presents Achievements at H.C. Wainwright Conference

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular...

RVLP : 0.0282 (-32.05%)
RVL Pharmaceuticals (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)

RVL Pharmaceuticals (NASDAQ: RVLP) is a a specialty pharmaceutical company whose near-term focus is to continue the rollout of UPNEEQ(R) into the medical aesthetics market through its dedicated sales force....

RVLP : 0.0282 (-32.05%)
RVL Pharmaceuticals (NASDAQ: RVLP) to Attend H.C. Wainwright Global Investment Conference

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company, recently announced that its CEO Brian Markison will be participating in a fireside chat and hosting 1-on-1 investor meetings during...

RVLP : 0.0282 (-32.05%)
Why RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, available by prescription...

RVLP : 0.0282 (-32.05%)
RVL Pharmaceuticals (NASDAQ: RVLP) to Participate at H.C. Wainwright Global Investment Conference

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment...

RVLP : 0.0282 (-32.05%)
RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, which is available by prescription...

RVLP : 0.0282 (-32.05%)
RVL Pharmaceuticals (NASDAQ: RVLP) Spotlighted in Cantor Fitzgerald Research Brief

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment...

RVLP : 0.0282 (-32.05%)
RVL Pharmaceuticals (NASDAQ: RVLP) Enters Agreements for $5M Registered Direct Offering

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment...

RVLP : 0.0282 (-32.05%)
RVL Pharmaceuticals (NASDAQ: RVLP) Announces Q2 2023 Results

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired...

RVLP : 0.0282 (-32.05%)
RVL Pharmaceuticals plc Reports Second Quarter 2022 Financial Results; Provides Commercial Update

-- Second quarter 2022 UPNEEQ® net product sales of $8.4 million; 42% above first quarter -- -- Opportunity for cash runway to extend through 2023...

RVLP : 0.0282 (-32.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

RVL Pharmaceuticals plc is a specialty pharmaceutical company. It focused on the commercialization and development of products which target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. RVL Pharmaceuticals plc, formerly known as Osmotica Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 0.0461
2nd Resistance Point 0.0421
1st Resistance Point 0.0351
Last Price 0.0282
1st Support Level 0.0241
2nd Support Level 0.0201
3rd Support Level 0.0131

See More

52-Week High 1.9100
Fibonacci 61.8% 1.1907
Fibonacci 50% 0.9685
Fibonacci 38.2% 0.7463
Last Price 0.0282
52-Week Low 0.0270

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar